1-6 of 6
Clifton C Mo, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A High Throughput Quantitative Seroproteomics Analysis of Multiple Myeloma Patients on Tagraxofusp Therapy Identifies Novel Cytokine-Assisted Mechanism of Action

Arghya Ray, PhD, Yan Song, PhD, Ting DU, PhD, Clifton C. Mo, MD, Arturo Olguin, Janice Chen, PhD, Christopher Brooks, PhD, Tariq I. Mughal, MD FRCP, Paul G. Richardson, MD, Dharminder Chauhan, PhD, Kenneth Anderson, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 34.
https://doi.org/10.1182/blood-2020-141571
Published: 2020
Journal Articles

A Phase I/II Study of Twice Weekly Ixazomib Plus Pomalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma: Results from Phase I Dose Escalation Cohorts

Omar Nadeem, MD, Clifton C Mo, MD, Jacob P. Laubach, MD, Giada Bianchi, MD, Robert Redd, Peter Barth, Trevor J. Bayliss, MD, Vaishali Sanchorawala, MD, Leyla Shune, MD, Alexandra Distaso, Virginia Dalton, MS, APRN, Adam S Sperling, MD PhD, Laura Amweg, Mary McKenney, NP, Kathleen Colson, BS,BSN,RN, Ella L Millard, Isabella Hou, Alexandra Savell, BS, Kelly Masone, BA, Nikhil C. Munshi, MD, Irene M. Ghobrial, MD, Kenneth Anderson, MD, Paul G. Richardson, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–2.
https://doi.org/10.1182/blood-2020-141549
Published: 2020
Journal Articles

Clinical Outcomes of Non-Traditional Lenalidomide, Bortezomib, and Dexamethasone Regimens in Multiple Myeloma

Shawn O. Streeter, PharmD, Omar Nadeem, MD, Paul G. Richardson, MD, Jacob P. Laubach, MD, Clifton C. Mo, MD, Kimberly Noonan, RN, NP, AOCN, Mary McKenney, NP, Tina Flaherty, ANP-BC, AOCN, Virginia Dalton, MS, APRN, Anil Aktas-Samur, PhD, Houry Leblebjian, PharmD, BCOP
Journal: Blood
Blood (2020) 136 (Supplement 1): 25–26.
https://doi.org/10.1182/blood-2020-143385
Published: 2020
Journal Articles

Defibrotide for the Treatment of Endotheliitis Complicating Sars-Cov-2 Infection: Rationale and Ongoing Studies As Part of the International Defacovid Study Group

Jose M. Moraleda, MD, Carmelo Carlo-Stella, MD, David Garcia-Bernal, PhD, Ruben Jara Rubio, MD, Enriqueta Andreu, MD, Eleonora Calabretta, MD, Alessio Aghemo, MD, Maribel Diaz-Ricart, Marta Palomo, PhD, Enric Carreras, MD PhD, Israel Vlodavsky, PhD, Massimo Iacobelli, Jawed Fareed, PhD, Pedro Castro, MD PhD, Sara Fernandez, MD, Clifton C. Mo, MD, Gerald L. Weinhouse, MD, Kenneth R. Cooke, MD, Robert J. Soiffer, MD, Rebecca M. Baron, MD, Peter O'Gorman, MD PhD FRCP, FRCPath, Gregory Yanik, MD, Antonio Pagliuca, MBBS, MA, FRCP, FRCPath, Paul G. Richardson, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 6–8.
https://doi.org/10.1182/blood-2020-141872
Published: 2020
Journal Articles

Phase I Study of On 01910.Na (rigosertib), a Multikinase PI3K Inhibitor in Relapsed/Refractory B-Cell Malignancies

Mark Roschewski, MD, Mohammed Farooqui, DO, Georg Aue, MD, Clifton C. Mo, MD, Janet Valdez, PA, Susan Soto, RN, Patricia Perez-Galan, PhD, Francois Wilhelm, MD, PhD., Adrian Wiestner, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1803.
https://doi.org/10.1182/blood.V120.21.1803.1803
Published: 2012
Journal Articles

Rapid Clearance of Rituximab Contributes to the Continued High Incidence of Autoimmune Complications of Chemoimmunotherapy for Chronic Lymphocytic Leukemia

Clifton C. Mo, MD, Mohammed Z.H. Farooqui, DO, Paul V. Beum, PhD, Ndegwa Njuguna, MD, Gerald E Marti, MD, PhD, Wyndham H. Wilson, MD, PhD, Ronald P. Taylor, PhD, Adrian U. Wiestner, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4628.
https://doi.org/10.1182/blood.V116.21.4628.4628
Published: 2010